famotidine has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, G | 1 |
| Hu, J | 1 |
| Li, T | 1 |
| Ma, X | 1 |
| Meng, J | 1 |
| Jia, M | 1 |
| Lu, J | 1 |
| Ohtsu, H | 1 |
| Chen, Z | 1 |
| Luo, X | 1 |
1 other study available for famotidine and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Famotidine; Heart; Heart Rate; Hist | 2012 |